| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥87.2B | ¥86.1B | +1.3% |
| Operating Income | ¥5.1B | ¥2.2B | +132.4% |
| Ordinary Income | ¥5.0B | ¥2.4B | +112.5% |
| Net Income | ¥3.2B | ¥2.2B | +44.2% |
| ROE | 3.5% | 2.5% | - |
FY2026 Q3 cumulative results: Revenue ¥87.2B (YoY +1.3%), Operating Income ¥5.1B (YoY +132.4%), Ordinary Income ¥5.0B (YoY +112.5%), Net Income ¥3.2B (YoY +44.2%). The company achieved substantial operating profit expansion driven by maintained high gross margin of 67.1% and effective SG&A expense control, with SG&A ratio declining to 61.2% of revenue. However, inventory turnover remains severely prolonged at 191 days, with cash conversion cycle extending to 382 days, warranting close monitoring of working capital efficiency. The company operates in the single cosmetics business segment with strong liquidity position holding ¥48.2B in cash and deposits against modest interest-bearing debt of ¥9.5B.
Revenue increased by 1.3% YoY to ¥87.2B, reflecting modest growth momentum in the cosmetics business. The company maintained a robust gross profit margin of 67.1% (¥58.5B), demonstrating strong pricing power and product mix quality. Operating profit surged 132.4% YoY from ¥2.2B to ¥5.1B, primarily driven by SG&A expense discipline where SG&A expenses of ¥53.3B represented 61.2% of revenue, an improvement from prior period levels. This operating leverage effect amplified the profitability impact despite modest top-line growth. Ordinary income grew 112.5% to ¥5.0B, closely tracking operating income with minimal non-operating impact. Net non-operating expense was approximately ¥0.1B, consisting primarily of interest expense of ¥0.1B. Extraordinary items contributed ¥0.3B gain, including ¥0.1B gain on sale of securities. Income tax expense of ¥1.8B resulted in an effective tax rate of 36.5%, which is elevated and compressed net income growth to 44.2% despite the 132.4% operating income expansion. The significant gap between operating income growth (+132.4%) and net income growth (+44.2%) is attributable to this high tax burden, representing approximately ¥1.8B tax expense against ¥5.0B pre-tax income. The business pattern follows revenue up/profit up trajectory, with profitability improvement significantly exceeding revenue growth through operational efficiency gains.
The company operates a single cosmetics business segment, which represents the core business contributing 100% of consolidated revenue and operating profit. No segment-level breakdown is available as the business is reported as a unified cosmetics operation.
[Profitability] ROE 3.5% (reported) reflects moderate return on equity with room for improvement against manufacturing sector benchmarks. Operating margin expanded to 5.9%, demonstrating operational leverage despite modest revenue growth, while net profit margin reached 3.7% constrained by elevated tax burden of 36.5%. The DuPont decomposition indicates net profit margin 3.6%, asset turnover 0.712, and financial leverage 1.35x contributing to the ROE outcome. [Cash Quality] Cash and deposits totaled ¥48.2B with strong short-term debt coverage of 24.1x against short-term borrowings of ¥2.0B, indicating substantial liquidity buffer. Current ratio stands at 388.4% and quick ratio at 323.9%, reflecting exceptionally strong liquidity position. However, inventory of ¥15.0B represents a significant portion of current assets with inventory turnover days extended to 191 days and cash conversion cycle at 382 days, indicating working capital efficiency challenges that may constrain cash generation quality. [Investment Efficiency] Asset turnover of 0.712 indicates moderate asset utilization efficiency with potential for improvement. Working capital of ¥67.1B remains elevated driven by inventory accumulation. [Financial Health] Equity ratio 74.3% demonstrates conservative capital structure with solid financial stability. Interest-bearing debt totaled ¥9.5B with debt-to-equity ratio of 0.35x and debt-to-capital ratio of 9.5%, indicating minimal leverage utilization. Interest coverage ratio approximates 40.8x, confirming strong debt servicing capacity. Short-term borrowings decreased significantly from ¥5.0B to ¥2.0B YoY (down 60%), reflecting deleveraging and reduced refinancing risk.
Cash and deposits increased to ¥48.2B, maintaining strong liquidity position supported by operating profit expansion. The substantial operating income growth of ¥2.9B YoY contributed to cash accumulation capacity. However, inventory increased ¥1.2B YoY to ¥15.0B (up 8.6%), representing continued working capital tie-up that constrains free cash generation. Trade receivables decreased ¥1.2B to ¥10.9B (down 10.0%), suggesting improved collection efficiency that partially offset inventory build. Short-term borrowings declined ¥3.0B to ¥2.0B (down 60.0%), indicating debt repayment activity that consumed cash but strengthened financial flexibility. The prolonged inventory turnover of 191 days and cash conversion cycle of 382 days signal that operating profit expansion has not fully translated into proportional cash generation, warranting focus on inventory monetization. Trade payables of ¥3.0B remain relatively modest, and the company maintains conservative supplier credit utilization. Cash coverage of short-term liabilities exceeds 24x, confirming ample near-term liquidity despite working capital efficiency concerns.
Ordinary income of ¥5.0B versus operating income of ¥5.1B indicates minimal non-operating impact with net non-operating expense of approximately ¥0.1B, primarily consisting of interest expense of ¥0.1B. Extraordinary income of ¥0.3B included ¥0.1B gain on sale of securities, representing a non-recurring element that modestly enhanced pre-tax income. Non-operating items represent less than 1% of revenue, indicating core earnings are predominantly driven by business operations. The absence of material asset impairments or restructuring charges supports earnings quality from a recurring standpoint. However, the elevated effective tax rate of 36.5% and the significant inventory accumulation (191-day turnover, 382-day cash conversion cycle) raise concerns about cash realization of reported earnings. While operating profit doubled, the lack of proportional cash flow generation due to working capital build suggests earnings quality requires monitoring until inventory normalization is achieved. The comprehensive income of ¥3.2B aligned with net income, with minimal other comprehensive income impact from securities valuation of negative ¥0.1B.
The company maintains full-year guidance of Revenue ¥125.5B, Operating Income ¥5.0B, Ordinary Income ¥4.9B, and EPS ¥126.93 with no revision this quarter. Q3 cumulative progress rates are: Revenue 69.5% (¥87.2B of ¥125.5B), Operating Income 102.6% (¥5.1B of ¥5.0B), and Ordinary Income 102.2% (¥5.0B of ¥4.9B). Operating income and ordinary income have already exceeded full-year targets by Q3, suggesting either conservative initial guidance or potential Q4 adjustments incorporating seasonal factors or planned investments. Revenue progress of 69.5% at Q3 is modestly below the standard 75% benchmark, indicating Q4 requires ¥38.3B (43.9% of full-year target) to achieve guidance, which represents significant sequential acceleration from the ¥29.1B quarterly average in Q1-Q3. The company forecasts annual dividend of ¥40.00, implying payout ratio of approximately 31.5% against forecasted EPS of ¥126.93. Contract liabilities of ¥3.2B provide forward revenue visibility representing approximately 3.7% of annual revenue guidance, indicating limited advance customer payment backlog relative to full-year scale.
The company forecasts annual dividend of ¥40.00 per share for FY2026. Based on cumulative Q3 EPS of ¥84.24 annualized (assuming similar Q4 performance), the implied payout ratio approximates 47.5%. Against the full-year forecasted EPS of ¥126.93, the payout ratio would be 31.5%, indicating conservative dividend policy with retained earnings for reinvestment or balance sheet flexibility. No share buyback activity has been disclosed for the current period. The dividend policy appears sustainable given strong cash position of ¥48.2B and modest debt levels, though attention to free cash flow generation quality remains important given working capital challenges. Total return ratio equals the payout ratio in absence of buybacks.
Inventory obsolescence and markdown risk: Inventory turnover extended to 191 days with cash conversion cycle of 382 days, significantly exceeding manufacturing sector median of 112 days. Prolonged inventory holding increases risk of product aging, particularly in cosmetics where consumer preferences shift and shelf-life matters, potentially forcing markdown pressure or write-downs that would compress future margins and cash flows. Revenue growth deceleration risk: YoY revenue growth of 1.3% trails the manufacturing sector median of 2.8%, indicating below-peer momentum. As a single-segment cosmetics business, the company faces concentration risk without diversification buffers, and failure to accelerate growth through new products or channel expansion could constrain profitability sustainability and shareholder return capacity. Tax rate sustainability concern: Effective tax rate of 36.5% exceeded ordinary corporate rates and materially compressed net income growth relative to operating profit expansion. If elevated tax rates persist due to non-deductible items or jurisdictional factors, net profitability and ROE will remain constrained despite operational improvements, limiting shareholder value creation relative to pre-tax performance.
[Industry Position] (Reference - Proprietary Analysis)
The company's profitability and financial health metrics present a mixed picture relative to manufacturing sector benchmarks. ROE of 3.5% substantially underperforms the industry median of 5.8% (2025-Q3, n=105), ranking in the lower quartile and indicating suboptimal capital efficiency despite conservative leverage. Operating margin of 5.9% also trails the sector median of 8.9% (IQR: 5.4%-12.7%), positioning near the lower end of typical manufacturing profitability. Net profit margin of 3.7% falls below the industry median of 6.5% (IQR: 3.3%-9.4%), reflecting both lower operating margins and elevated tax burden. Equity ratio of 74.3% exceeds the sector median of 63.8% (IQR: 49.1%-74.8%), indicating above-average financial stability and conservative capital structure that provides downside protection but may constrain ROE through underleveraging. Current ratio of 388.4% significantly surpasses the industry median of 2.87x (IQR: 2.13x-3.84x), reflecting exceptional liquidity strength. However, inventory turnover of 191 days materially exceeds the sector median of 112 days (IQR: 50-163 days), highlighting a critical working capital efficiency gap. Asset turnover of 0.712 exceeds the sector median of 0.56 (IQR: 0.41-0.65), suggesting relatively better asset utilization despite inventory challenges. Revenue growth of 1.3% lags the industry median of 2.8% (IQR: -1.5%-8.8%), indicating below-median organic momentum. The company's financial leverage of 1.35x is conservative versus the sector median of 1.53x (IQR: 1.31-1.86x), consistent with its high equity ratio and low debt utilization.
(Industry: Manufacturing, Comparison period: 2025-Q3, Source: Proprietary analysis)
Operating leverage realization with margin expansion trajectory: The company demonstrated substantial operating profit growth of 132.4% on modest 1.3% revenue growth, driven by gross margin maintenance at 67.1% and SG&A ratio compression to 61.2%. This indicates successful cost control and operating leverage that, if sustained, could drive meaningful profitability improvement as revenue growth accelerates, though execution on top-line growth remains a key dependency.
Working capital efficiency represents critical value unlock opportunity and risk: Inventory turnover of 191 days and cash conversion cycle of 382 days significantly exceed manufacturing sector norms (median 112 days inventory turnover), indicating substantial cash tied in working capital. Successful inventory normalization could release meaningful cash for shareholder returns or growth investment, while continued deterioration would constrain cash generation quality and raise markdown risk in the cosmetics business where product freshness matters.
Conservative financial position provides stability but constrains ROE potential: Equity ratio of 74.3% and minimal leverage (debt-to-equity 0.35x) alongside ¥48.2B cash position afford strong financial flexibility and downside protection. However, ROE of 3.5% trails industry median of 5.8%, suggesting the conservative capital structure and underleveraging limit return potential. Strategic capital allocation decisions regarding balance sheet optimization, shareholder returns, or growth investment will be important to improve capital efficiency while maintaining financial stability.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.